The effect of intramuscular injection of spiramycin at therapeutic dose on some blood biochemical and hematological parameters in Assaf sheep


  • I. Al Zuheir Faculty of Veterinary Medicine, a Najah National University, Nablus, Palestine
  • M. Abdaldayem Faculty of Veterinary Medicine, a Najah National University, Nablus, Palestine


Spiramycin, Blood biochemical parameters, Hematological parameters, Assaf sheep


Spiramycin is used to treatment of different bacterial and protozoal infection in different animal species including sheep, to the authors’ knowledge there are no studies about effects of spiramycin in sheep blood biochemical and hematological parameters. This study was designated to determine the effects of spiramycin intramuscular treatment at therapeutic dose (64,000 IU/kg) for five days in some blood biochemical and hematological parameters in healthy Assaf sheep (n=8). The results showed that spiramycin treatment caused decrease in calcium and creatinine level (P<0.05) without significant change in albumin, total protein, magnesium, glucose and the adjusted calcium level (P>0.05). After treatment, hematological parameters tend to decrease toward normal references range of red blood cell count, haemoglobin concentration, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration and red blood cell distribution width (P<0.05). No changes were observed in hematocrit, mean corpuscular volume, platelet count and mean platelet volume (P>0.05). All the measured biochemical and hematological parameters were in the normal references range after the treatment. These results suggested that spiramycin given in therapeutic regimen to healthy Assaf sheep caused only minor inconclusive changes in the measured hematological and biochemical profiles; and thus can be used safely in treating susceptible infections in sheep. These results might be accepted as a starting point for future experiments to evaluate the effects spiramycin on the different systems and parameters.


Abou-Zeid, A.Z., el-G Khalil A., Rabei M., 1980. Spiramycin, a macrolide antibiotic. Zentralbl Bakteriol Naturwiss,


Al-Zanbagi, N.A., 2007. Effectiveness of Myrrh and Spiramycin as Inhibitors for Toxoplasma gondii Tachyzoites In

Vivo. Mansoura J. Forensic Med. Clin. Toxicol., 15, 117-128.

Arzey, G.G., Arzey K.E, 1992. Successful treatment of mycoplasmosis in layer chickens with single dose therapy.

Aust Vet J. 69,126-8.

Barton, M.D., 2000. Antibiotic use in animal feed and its impact on human health. Nutr Res Rev., 13, 279-300.

Bickhardt, K., Düngelhoef R., 1994. Clinical studies of kidney function in sheep. I. Methods and reference values of

healthy animal. Dtsch Tierarztl Wochenschr, 101,463-6.

Cester, C.C., Laurentie, M.P., Garcia-Villar, R., Toutain P.L., 1990. Spiramycin concentrations in plasma and genitaltract secretions after intravenous administration in the ewe. J. vet. Pharmacol. Therap., 13, 7-14.

Chaichisemsari, M., Eshratkhah, B., Maherisis, N., Sadaghian, M., Hassanpour S., 2011. Evaluation of Total Protein,

Albumin, Globulin and Blood Urea Nitrogen Concentrations in Gastrointestinal Nematodes Infected Sheep.

Global Vetennaria, 6, 433-437.

Davies, R. J., Pepys J., 1975. Asthma due to inhaled chemical agents-the macrolide antibiotic Spiramycin. Clin. Exp.

Allergy 5, 99-107.

Denie, C., Henrion, J., Schapira, M., A. Schmitz, Heller, F.R., 1992. Spiramycin-induced cholestatic hepatitis. J

Hepatol., 16, 386.

Duncan, J.R., Prasse K.W., Mahaffey E.A, 1994. Veterinary laboratory medicine. Clinical pathology, 3rd Edn. Iowa

State University Press. Iowa, pp, 271-272.

Gratzl, R., Sodeck, G., Platzer, P., Jager, W., Graf, J., Pollak, A., Thalhammer, T., 2002. Treatment of toxoplasmosis

in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid. Eur J

Clin Microbiol Infect Dis., 21,12–16

Kerr, M.G., 1991. Veterinary Laboratory Medicine: clinical Biochemistry and Haematology; 2nd Edn. Oxford

Blackwell Scientific Publication. pp, 108

Nielsen, P., Gyrd-Hansen, N., 1998. Bioavailability of spiramycin and lincomycin after oral administration to fed and

fasted pigs. J. vet. Pharmacol. Therap. 21, 251-256.

Pennisi, M.G., De-Majo, M., Masucci, M., Britti, D., Vitale, F., Del-Maso, R., 2005. Efficacy of the treatment of dogs

with leishmaniosis with a combination of metronidazole and spiramycin. Vet Rec. 156,346-349.

Pyörälä, S.H., Pyörälä, E.O., 1998. Efficacy of parenteral administration of three antimicrobial agents in treatment

of clinical mastitis in lactating cows, 487 cases (1989-1995). J Am Vet Med Assoc. 212,407-412.

Saab, Y.B., Mroueh, M., 2002. Spiramycin-induced liver injury. Ann. Pharmacother. 36,1972.

Sarma P.S. 1997. Oxidative haemolysis after spiramycin. Postgrad Med J., 73,686-687.

The Merck Veterinary Manual. Reference Guides [on line]., 2011., URL:

Yankell, S.L., F.C. Leung, Gardner J.M., Paor W. S., 1974. Spiramycin excretion in animals: III. A single oral dose in

dogs. J Dent Res., 53, 364-368.



How to Cite

Al Zuheir, I. ., & Abdaldayem, M. . (2012). The effect of intramuscular injection of spiramycin at therapeutic dose on some blood biochemical and hematological parameters in Assaf sheep. Scientific Journal of Veterinary Advances, 1(6), 142-146. Retrieved from



Original Article